ROSELAND, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced a strategic partnership with Axial Biologics, a premier medical device company with a vast distribution network. Under the agreement, Axial Biologics will serve as the distributor of Milestone Scientific's CompuFlo® Epidural System in New Jersey, Texas, and Florida. This partnership immediately fol ...

TRD, U.S.A. President David Wilson announces retirement Appointment of Tyler Gibbs to TRD, U.S.A. President PLANO, Texas, Aug. 7, 2024 /PRNewswire/ -- Toyota Motor North America (TMNA) today announced executive leadership changes as David Wilson, group vice president and president of TRD, U.S.A. (Toyota Racing Development), will retire on December 16 after 35 years with the organization. General Manager Tyler Gibbs will succeed Wilson as president of TRD, a subsidiary of Toyota Motor North America (TMNA). ...

TEL AVIV, Israel, Aug. 07, 2024 (GLOBE NEWSWIRE) --  PainReform Ltd. (NASDAQ:PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announced compelling safety data for its lead product candidate, PRF-110. This data, derived from pharmacokinetic (PK) studies in both herniorrhaphy and bunionectomy clinical trials, highlights PRF-110's promising safety profile, with maximum blood levels (Cmax) recorded at approxi ...

RESEARCH TRIANGLE PARK, N.C., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE:ASXC), a global leader of innovative digital solutions for the operating room, today announced that the Company's Special Meeting of Stockholders, scheduled to be held on Wednesday, August 7, 2024 at 10:00 a.m. (Eastern Time), was adjourned to Tuesday, August 20, at 10:00 a.m. (Eastern Time). The Special Meeting will be held virtually. While we have received proxies for approximately 52% of our outstanding shares wi ...

文章核心观点 - 公司是一家专注于罕见疾病治疗的公司 [3] - 公司正在开发创新性的治疗方法来解决罕见疾病领域的挑战 [3] - 公司将在Canaccord Genuity's 44th Annual Growth Conference上进行演讲 [1][2] 公司概况 - 公司名称为Zevra Therapeutics Inc [1] - 公司股票代码为NASDAQ:ZVRA [1] - 公司总裁兼首席执行官为Neil F. McFarlane [1] - 公司将提供一对一的投资者会议 [1] - 公司提供扩展访问计划以满足患者需求 [4] 公司发展战略 - 公司采用独特的数据驱动的开发和商业化策略 [3] - 公司正在克服复杂的药物开发挑战,为罕见疾病患者提供新的治疗方法 [3]

A significant milestone for Vaso's Listing on NASDAQ Vaso Stockholders Meeting Scheduled for August 26, 2024 to Approve Business Combination with Achari PLAINVIEW, N.Y., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Vaso Corporation ("Vaso" or the "Company") (OTCQX:VASO) announced that on August 5, 2024, the U.S. Securities and Exchange Commission ("SEC") declared effective the Achari Ventures Holdings Corp. I ("Achari") (NASDAQ:AVHI) Registration Statement on Form S-4, as amended (the "Registration Statement"), filed ...

文章核心观点 - 公司宣布首席审计执行官Christine Tvaroch退休,由Ronda Edkins接任该职位 [2][3] - 公司高管对Tvaroch的贡献表示感谢,并认为Edkins的加入将有助于公司的企业风险管理和应对更高监管标准 [3][5] - Tvaroch在公司工作近30年,曾担任多个审计相关职位,Edkins拥有25年金融服务行业经验 [4][7] 公司概况 - 公司总部位于宾夕法尼亚州匹兹堡,是一家多元化的金融服务公司,在7个州和哥伦比亚特区开展业务 [8] - 公司资产规模接近480亿美元,拥有约350家银行网点 [8] - 公司提供全面的商业银行、个人银行和财富管理解决方案 [9] 首席审计执行官职责 - 负责向公司审计委员会和董事会提供独立保证,评估公司的治理、风险和控制流程的有效性 [6] - 领导团队评估财务、运营和信息技术控制,确保符合公司政策和政府法规 [6]

SUGAR LAND, Texas, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Team, Inc. (NYSE:TISI) ("TEAM" or the "Company"), a global, leading provider of specialty industrial services offering clients access to a full suite of conventional, specialized, and proprietary mechanical, heat-treating, and inspection services, today announced that it will issue its second quarter 2024 earnings release on Thursday, August 8, 2024 after the close of trading on the New York Stock Exchange. TEAM will host a conference call to discuss its ...

AUSTIN, Texas, Aug. 7, 2024 /PRNewswire/ -- Ideal Power Inc. (Nasdaq: IPWR) ("Ideal Power," the "Company," "we," "us" or "our"), pioneering the development and commercialization of the highly efficient and broadly patented B-TRAN™ bidirectional semiconductor power switch, today announces the Company is collaborating with a third global automaker. This global automaker is working closely and meeting regularly with Ideal Power engineers on the use of B-TRAN™-enabled contactors to potentially replace electrome ...

BERKELEY HEIGHTS, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC, NASDAQ:CYCCP, ", Cyclacel", or the ", Company", ))), a biopharmaceutical company developing innovative medicines based on cancer cell biology, will announce second quarter 2024 financial results on Wednesday, August 14, 2024. The Company will host a conference call and live webcast at 4:30 p.m. Eastern Daylight Time on the same day. Conference call information: Call: (800) 225-9448 / international call: (2 ...